Lovastatin promotes the self-renewal of murine and primate spermatogonial stem cells

• DOI: 10.1016/j.stemcr.2023.02.011
• Publication Date: 2023-04-11T14:51:01Z
• Authors: Chaohui Li; Zhaokai Yao; Linzi Ma; Xiuling Song; Wen Wang; Cong Wan; Shaofang Ren; Dingyao Chen; Yi Zheng; Yong-tong Zhu; Gang Chang; Shihao Wu; Kai Miao; Fang Luo; Xiao-Yang Zhao
• Keywords: Male; Primates; Mice; Stem Cells; Animals; Humans; Lovastatin; Spermatogenesis; Article; Spermatogonia; Infertility, Male; Cell Proliferation

The spermatogonial stem cell (SSC) niche is critical for SSC maintenance and subsequent spermatogenesis. Numerous reproductive hazards impair the SSC niche, thereby resulting in aberrant SSC self-renewal and male infertility. However, promising agents targeting the impaired SSC niche to promote SSC self-renewal are still limited. Here, we screen out and assess the effects of Lovastatin on the self-renewal of mouse SSCs (mSSCs). Mechanistically, Lovastatin promotes the self-renewal of mSSCs and inhibits its inflammation and apoptosis through the regulation of isoprenoid intermediates. Remarkably, treatment by Lovastatin could promote the proliferation of undifferentiated spermatogonia in the male gonadotoxicity model generated by busulfan injection. Of note, we demonstrate that Lovastatin could enhance the proliferation of primate undifferentiated spermatogonia. Collectively, our findings uncover that lovastatin could promote the self-renewal of both murine and primate SSCs and have implications for the treatment of certain types of male infertility using small compounds.